Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-27 · accession 0001628280-24-013828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | 2024-03-27 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $17.99 | -395 | 159.1K | -0.2% | -$7,106 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-27 | S | D | 395 | $17.99 | 159,145 | D | — | — |